以微生物群为中心的干预措施,以促进免疫检查点阻塞疗法
Andrew A Almonte1,2, Simon Thomas1,2,3, Laurence Zitvogel1,2,3,4
1Gustave Roussy Cancer Campus, Clinicobiome , Villejuif, France.
The Journal of experimental medicine
|April 22, 2025
概括
操纵肠道微生物组可能会提高癌症免疫治疗的有效性. 本综述探讨了针对肠道微生物的方法,以获得更好的治疗结果,并讨论了微生物失衡的诊断工具.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 免疫检查点阻塞 (ICB) 疗法彻底改变了癌症治疗,通过增强抗瘤免疫力来改善患者的生存率.
- 然而,仍然存在重大挑战,包括治疗耐药性和与免疫相关的不良事件.
- 越来越多的证据将肠道微生物失调与降低的ICB疗效联系在一起,而多样化的肠道微生物群和特定的有益细菌与更好的反应有关.
研究的目的:
- 审查当前操纵肠道微生物组的策略,以提高癌症治疗的疗效.
- 检查用于检测肠道疾病的新型诊断工具.
- 突出现有挑战和微生物向癌症免疫治疗的未来方向.
主要方法:
- 关于研究肠道微生物组在癌症免疫治疗中的作用的文献综述.
- 对针对肠道微生物群的新兴治疗方法的分析.
- 对微生物失生症的诊断技术的评估.
主要成果:
- 肠道微生物组成显著影响对免疫检查点封锁的反应.
- 特定的细菌种群和整体肠道微生物多样性与改善治疗结果相关.
- 准肠道微生物组是克服治疗耐药性的有希望的途径.
结论:
- 调节肠道微生物群具有显著的潜力,可以提高癌症免疫疗法的疗效.
- 开发精确的诊断工具对于识别可能从微生物干预中受益的患者至关重要.
- 需要进一步的研究来解决微生物组操纵的挑战,以优化癌症治疗.
相关概念视频
Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80


